You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 140 No. 3, March 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  This Month in Archives of Dermatology
 This Article
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

This Month in Archives of Dermatology

Arch Dermatol. 2004;140:271.

The Course of Chronic Plaque-Type Psoriasis in Placebo Groups of Randomized Controlled Studies

In studies of therapeutic efficacy, placebo-controlled trials are essential. This is especially true for diseases such as psoriasis in which the natural course may vary considerably from patient to patient, with variations including chronic persistence of lesions as well as spontaneous and temporary or persistent remissions or exacerbations. Placebo effects influence treatment outcomes in up to 35% of patients. In this systematic review of randomized placebo-controlled trials of systemic drugs for chronic plaque-type psoriasis, Spuls et al found considerable variation in treatment outcomes in placebo groups. Publication bias and variations in study design and documentation may account for some of this variation.

(SEE ARTICLE)


An Optimal Method for Experimental Provocation of Polymorphic Light Eruption

The most common idiopathic photodermatosis, polymorphic light eruption (PLE), is characterized by a delayed abnormal reaction to UV radiation. After a critical review of the literature, van de Pas et al performed photoprovocation studies on 25 patients to develop a reliable provocation method for PLE. The wavelength dependence of PLE remains unclear, and the action spectrum of the disease has been disparately reported to be in the UV-A range, the UV-B range, or both. In this study, solar-simulated radiation was found to be very effective in provoking PLE, which suggests that PLE may be most readily induced when the natural causes of the disease are simulated. Such a protocol could be particularly beneficial in the assessment of potential photoprotective agents.

(SEE ARTICLE)


Pemphigus Vulgaris Acantholysis Ameliorated by Cholinergic Agonists

Pemphigus vulgaris (PV) is an autoimmune, IgG autoantibody–mediated, mucocutaneous disease characterized by progressive blistering and nonhealing erosions. Corticosteroids remain the mainstay of therapy through immunosuppression as well as a direct blocking effect on IgG-induced acantholysis. Activation of keratinocyte cholinergic receptors mimics the antiacantholytic effects of corticosteroids, which prompted Nguyen et al to evaluate whether cholinomimetic agents may represent novel antiacantholytic therapy for this chronic disease. Using a mouse model of pemphigus, the authors demonstrate that the cholinergic agonist carbachol attenuated the effects of PV IgG on keratinocytes. The usefulness of pyridostigmine bromide in a single patient with PV is also discussed.

(SEE ARTICLE)


Increased Prevalence of Human Papillomavirus in Hairs Plucked From Patients With Psoriasis Treated With Psoralen–UV-A

Psoralen–UV-A (PUVA) treatment of psoriasis is linked to an increased risk of cutaneous malignancy, but the precise causes are not well understood. In this study, Wolf et al demonstrate that PUVA may promote carcinogenesis by acting as a cofactor for tumorigenic viruses such as human papillomaviruses (HPVs). Using a nested polymerase chain reaction approach, the authors found a higher incidence of HPV in plucked hair follicles of patients with psoriasis treated with PUVA than in those of non–PUVA-treated patients. The high incidence of epidermodysplasia verruciformis HPVs, including HPV 38, in PUVA-treated patients may be directly involved in tumorigenesis.



(SEE ARTICLE)


Differential Expression of Cytokines in UV-B–Exposed Skin of Patients With Polymorphous Light Eruption

Ultraviolet radiation can modify proteins and other organic molecules that may act as neoantigens to provoke an autoimmune reaction. On the other hand, the cytokine balance in UV-exposed skin is shifted toward an immunosuppressive reaction in healthy individuals. A defect in UV-induced immunosuppression may explain the inflammatory reaction in the skin of patients with polymorphous light eruption (PLE). Kölgen et al overexposed unaffected buttock skin of 6 patients with PLE and 5 healthy volunteers to UV-B and performed immunohistochemical staining on frozen skin sections for a number of cytokines. A reduced induction of tumor necrosis factor {alpha}, which affects Langerhans cell migration, provides confirmation of a defect in UV-induced immunosuppression in PLE.

(SEE ARTICLE)

SECTION EDITOR: ROBIN L. TRAVERS, MD







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.